These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25257072)

  • 1. New strategies for the management of patients with homozygous familial hypercholesterolaemia.
    Catapano AL
    Atheroscler Suppl; 2014 Sep; 15(2):17-8. PubMed ID: 25257072
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of homozygous familial hypercholesterolaemia--unmet needs, updated recommendations, and clinical experience with the MTP inhibitor, lomitapide. Concluding comments.
    Catapano AL
    Atheroscler Suppl; 2014 Sep; 15(2):52. PubMed ID: 25257077
    [No Abstract]   [Full Text] [Related]  

  • 3. Recommendations for the management of patients with homozygous familial hypercholesterolaemia: overview of a new European Atherosclerosis Society consensus statement.
    Bruckert E
    Atheroscler Suppl; 2014 Sep; 15(2):26-32. PubMed ID: 25257074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of European and US guidelines for familial hypercholesterolaemia.
    Reiner Ž
    Curr Opin Lipidol; 2015 Jun; 26(3):215-20. PubMed ID: 25943839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society].
    Cuchel M; Bruckert E; Ginsberg HN; Raal FJ; Santos RD; Hegele RA; Kuivenhoven JA; Nordestgaard BG; Descamps OS; Steinhagen-Thiessen E; Tybjaerg-Hansen A; Watts GF; Averna M; Boileau C; Borén J; Catapano AL; Defesche JC; Hovingh GK; Humphries SE; Kovanen PT; Masana L; Pajukanta P; Parhofer KG; Ray KK; Stalenhoef AF; Stroes E; Taskinen MR; Wiegman A; Wiklund O; Chapman MJ;
    Turk Kardiyol Dern Ars; 2015 Mar; 43 Suppl 1():1-14. PubMed ID: 27326442
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical experience of lomitapide therapy in patients with homozygous familial hypercholesterolaemia.
    Cuchel M; Blom DJ; Averna MR
    Atheroscler Suppl; 2014 Sep; 15(2):33-45. PubMed ID: 25257075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the treatment of homozygous familial hypercholesterolaemia.
    Marais AD; Blom DJ
    Curr Opin Lipidol; 2013 Aug; 24(4):288-94. PubMed ID: 23839331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in familial hypercholesterolaemia in children.
    Reijman MD; Kusters DM; Wiegman A
    Lancet Child Adolesc Health; 2021 Sep; 5(9):652-661. PubMed ID: 34119028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracorporeal treatment of hypercholesterolaemia.
    Olbricht CJ
    Nephrol Dial Transplant; 1993; 8(9):814-20. PubMed ID: 8255513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of lipoprotein apheresis in homozygous familial hypercholesterolaemia.
    Meier P; Blanc E
    Nephrol Dial Transplant; 2000 May; 15(5):738-40. PubMed ID: 10809830
    [No Abstract]   [Full Text] [Related]  

  • 11. Guideline will aid early detection of familial hypercholesterolaemia.
    Savill P
    Practitioner; 2008 Oct; 252(1711):30, 32-3. PubMed ID: 18972797
    [No Abstract]   [Full Text] [Related]  

  • 12. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
    Watts GF; Gidding S; Wierzbicki AS; Toth PP; Alonso R; Brown WV; Bruckert E; Defesche J; Lin KK; Livingston M; Mata P; Parhofer KG; Raal FJ; Santos RD; Sijbrands EJ; Simpson WG; Sullivan DR; Susekov AV; Tomlinson B; Wiegman A; Yamashita S; Kastelein JJ
    Int J Cardiol; 2014 Feb; 171(3):309-25. PubMed ID: 24418289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homozygous familial hypercholesterolaemia and treatment by LDL apheresis.
    King RI; Scott RS; Florkowski CM; Laurie AD; Reid N; George PM
    N Z Med J; 2010 Jul; 123(1319):79-82. PubMed ID: 20717180
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hypercholesterolaemia.
    Nair DR; Sharifi M; Al-Rasadi K
    Curr Opin Cardiol; 2014 Jul; 29(4):381-8. PubMed ID: 24870549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New EAS Consensus Statement on FH: improving the care of FH patients.
    Stock J
    Atherosclerosis; 2013 Nov; 231(1):69-71. PubMed ID: 24125413
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the integrated guidance on the care of familial hypercholesterolaemia.
    Arai H; Ding YA; Yamashita S
    J Atheroscler Thromb; 2014; 21(4):366-7. PubMed ID: 24573014
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE guidance on familial hypercholesterolaemia: all sugar and spice?
    Watts GF; Hamilton-Craig I; Sullivan DR
    Heart Lung Circ; 2009 Jun; 18(3):181-3. PubMed ID: 19119070
    [No Abstract]   [Full Text] [Related]  

  • 19. What are we able to achieve today for our patients with homozygous familial hypercholesterolaemia, and what are the unmet needs?
    Santos RD
    Atheroscler Suppl; 2014 Sep; 15(2):19-25. PubMed ID: 25257073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods].
    Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M
    Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.